These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26551872)

  • 1. Immobilization of bioactive plasmin reduces the thrombogenicity of metal surfaces.
    Wise SG; Michael PL; Waterhouse A; Santos M; Filipe E; Hung J; Kondyurin A; Bilek MM; Ng MK
    Colloids Surf B Biointerfaces; 2015 Dec; 136():944-54. PubMed ID: 26551872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces.
    Hansi C; Arab A; Rzany A; Ahrens I; Bode C; Hehrlein C
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):488-96. PubMed ID: 19235237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of surface texture and charge on the biocompatibility of endovascular stents.
    Hehrlein C; Zimmermann M; Metz J; Ensinger W; Kübler W
    Coron Artery Dis; 1995 Jul; 6(7):581-6. PubMed ID: 7582197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical device-induced thrombosis: what causes it and how can we prevent it?
    Jaffer IH; Fredenburgh JC; Hirsh J; Weitz JI
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S72-81. PubMed ID: 26149053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biologically active surface enzyme assembly that attenuates thrombus formation.
    Qu Z; Muthukrishnan S; Urlam MK; Haller CA; Jordan SW; Kumar VA; Marzec UM; Elkasabi Y; Lahann J; Hanson SR; Chaikof EL
    Adv Funct Mater; 2011 Dec; 21(24):4736-4743. PubMed ID: 23532366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo biocompatibility of a plasma-activated, coronary stent coating.
    Waterhouse A; Wise SG; Yin Y; Wu B; James B; Zreiqat H; McKenzie DR; Bao S; Weiss AS; Ng MK; Bilek MM
    Biomaterials; 2012 Nov; 33(32):7984-92. PubMed ID: 22889486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents.
    Waterhouse A; Yin Y; Wise SG; Bax DV; McKenzie DR; Bilek MM; Weiss AS; Ng MK
    Biomaterials; 2010 Nov; 31(32):8332-40. PubMed ID: 20708259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanically Robust Plasma-Activated Interfaces Optimized for Vascular Stent Applications.
    Santos M; Filipe EC; Michael PL; Hung J; Wise SG; Bilek MM
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9635-50. PubMed ID: 27015083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Improving Endothelial Cell Adhesion to Blood-Contacting Medical Devices.
    Wolfe JT; Shradhanjali A; Tefft BJ
    Tissue Eng Part B Rev; 2022 Oct; 28(5):1067-1092. PubMed ID: 34693761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of stent surface on thrombogenicity and vascular healing: a comparative analysis of metallic and polymeric surfaces.
    Eppihimer MJ; Sushkova N; Grimsby JL; Efimova N; Kai W; Larson S; Forsyth B; Huibregtse BA; Dawkins KD; Wilson GJ; Granada JF
    Circ Cardiovasc Interv; 2013 Aug; 6(4):370-7. PubMed ID: 23899869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on the thrombogenicity of surface oxide properties of 316l stainless steel for biomedical applications.
    Shih CC; Shih CM; Su YY; Lin SJ
    J Biomed Mater Res A; 2003 Dec; 67(4):1320-8. PubMed ID: 14624519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimicking the fibrinolytic system on material surfaces.
    Li D; Chen H; Brash JL
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):1-6. PubMed ID: 21543195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents.
    Henn C; Satzl S; Christoph P; Kurz P; Radeleff B; Stampfl U; Stampfl S; Berger I; Richter GM
    J Vasc Interv Radiol; 2008 Mar; 19(3):427-37. PubMed ID: 18295704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility and hemocompatibility of surface-modified NiTi alloys.
    Armitage DA; Parker TL; Grant DM
    J Biomed Mater Res A; 2003 Jul; 66(1):129-37. PubMed ID: 12833439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces.
    Yin Y; Wise SG; Nosworthy NJ; Waterhouse A; Bax DV; Youssef H; Byrom MJ; Bilek MM; McKenzie DR; Weiss AS; Ng MK
    Biomaterials; 2009 Mar; 30(9):1675-81. PubMed ID: 19157535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental influences on endovascular stent platelet reactivity: an in vitro comparison of stainless steel and gold surfaces.
    Kolandaivelu K; Edelman ER
    J Biomed Mater Res A; 2004 Aug; 70(2):186-93. PubMed ID: 15227663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro hemocompatibility and vascular endothelial cell functionality on titania nanostructures under static and dynamic conditions for improved coronary stenting applications.
    Mohan CC; Chennazhi KP; Menon D
    Acta Biomater; 2013 Dec; 9(12):9568-77. PubMed ID: 23973390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization.
    Zhang K; Liu T; Li JA; Chen JY; Wang J; Huang N
    J Biomed Mater Res A; 2014 Feb; 102(2):588-609. PubMed ID: 23520056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of thrombus-resistant and cell compatible crimped polyethylene terephthalate cardiovascular grafts using surface co-immobilized heparin and collagen.
    Al Meslmani B; Mahmoud G; Strehlow B; Mohr E; Leichtweiß T; Bakowsky U
    Mater Sci Eng C Mater Biol Appl; 2014 Oct; 43():538-46. PubMed ID: 25175248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
    Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
    J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.